Danish drugmaker Lundbeck lowers （株主への）配当 範囲 to 燃料 growth
By Jacob Gronholt-Pedersen
COPENHAGEN, Feb 5 (Reuters) - Drugmaker Lundbeck will lower （株主への）配当s as it 捜し出すs to 増加する 投資 to 反対する 拒絶する／低下するing sales of older 麻薬s, it said on Tuesday, sending its 株 負かす／撃墜する 3.6 パーセント.
Lundbeck, which specialises in neurological and psychological 病気s such as 不景気 and Alzheimer's, is under 圧力 from generic 競争 as 特許s of 存在するing 麻薬s 満了する／死ぬ.
The Danish company said it would 支払う／賃金 30-60 パーセント of 逮捕する 利益（をあげる） in （株主への）配当s instead of 60-80 パーセント, 目的（とする）ing to 上げる its 財政上の muscle for 取得／買収s and new 共同s to return to growth.
"We're not 圧力（をかける）d to do the first thing that comes along. We have a sense of 緊急 but not a sense of panic," 大統領 Deborah Dunsire told Reuters.
Dunsire took over as 長，指導者 (n)役員／(a)執行力のある in September last year after former CEO Kaare Schultz was poached by Teva in 2017.
Lundbeck's 株 price had more than ３倍になるd under Schultz, whose cust-cutting programme 回復するd profitability at the company.
However, the 株 price has 宙返り／暴落するd by 40 パーセント since August after Lundbeck 改訂するd its 十分な-year 利益（をあげる） 見通し and then 発表するd an 不成功の 段階 III 臨床の 裁判，公判 of a 麻薬 for 治療-抵抗力のある schizophrenia.
The 在庫／株 was 貿易（する）ing 3.6 パーセント 負かす／撃墜する at 1121 GMT on Tuesday.
The 焦点（を合わせる） on brain disorders has 増加するd with big 製薬の companies 潜在的に coming 支援する into the field, Dunsire said.
運動ing the market is a rise in 事例／患者s of 地位，任命する-traumatic 強調する／ストレス disorder, 苦悩 disorders and 不景気, 同様に as neurological 病気s such as Alzheimer's の中で ageing 全住民s.
Lundbeck 推定する／予想するs sales of epilepsy disorder 麻薬 Onfi, its biggest brand, to slide その上の after the 特許 満了する／死ぬd in October last year.
To 生き返らせる growth the company will look to buy 麻薬s in 段階 3 臨床の 裁判，公判 or 製品s that are ready for the market.
"Those are n ot 厚い on the ground and they're expensive," said Dunsire.
"But we don't feel we're standing on a 燃やすing 壇・綱領・公約," she 追加するd, referring to the strong profitability of its 存在するing 製品s.
The company said it 推定する／予想するs 2019 歳入 between 16.1 billion Danish 栄冠を与えるs ($2.47 billion) and 16.7 billion 栄冠を与えるs, 負かす／撃墜する from 18.1 billion 栄冠を与えるs last year.
Fourth-４半期/4分の1 sales stood at 4.2 billion 栄冠を与えるs, 負かす／撃墜する 4 パーセント year on year but above the 4.09 billion 推定する／予想するd by 分析家s in a 投票. Operating 利益（をあげる） （機の）カム in at 848 million 栄冠を与えるs, against 分析家 期待s of 889 million 栄冠を与えるs. ($1 = 6.5308 Danish 栄冠を与えるs) (報告（する）／憶測ing by Jacob Gronholt-Pedersen Editing by Louise Heavens and David Goodman)
